We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$3.78B
AUM Growth
-$233M
Cap. Flow
-$264M
Cap. Flow %
-6.98%
Top 10 Hldgs %
23.24%
Holding
695
New
198
Increased
109
Reduced
142
Closed
212

Sector Composition

Rank Sector Weight
1 Real Estate 27.96%
2 Technology 8.92%
3 Financials 6.08%
4 Utilities 5.97%
5 Industrials 4.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLPH
451
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$300K 0.01%
+15,000
New +$307K
ATRC icon
452
AtriCure
ATRC
$1.77B
$298K 0.01%
10,000
KYNB
453
Kyntra Bio
KYNB
$28.5M
$294K 0.01%
260
-1,140
-81% -$1.25M
TPCO
454
DELISTED
Tribune Publishing Company Common Stock
TPCO
$284K 0.01%
35,621
-16,479
-32% -$170K
IDXX icon
455
Idexx Laboratories
IDXX
$42.9B
$275K 0.01%
999
-1,001
-50% -$247K
GME icon
456
PUT
GameStop
GME
$9.5B
$274K 0.01%
+200,000
New +$391K
ITCI
457
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$273K 0.01%
+21,000
New +$269K
VYGR icon
458
Voyager Therapeutics
VYGR
$187M
$272K 0.01%
+10,000
New +$229K
OBSV
459
DELISTED
ObsEva SA Ordinary Shares
OBSV
$260K 0.01%
23,000
RCKT icon
460
Rocket Pharmaceuticals
RCKT
$348M
$255K 0.01%
17,000
+4,500
+36% +$78.5K
ZGNX
461
DELISTED
Zogenix, Inc.
ZGNX
$239K 0.01%
5,000
-8,000
-62% -$322K
XENT
462
CALL
DELISTED
Intersect ENT, Inc
XENT
$228K 0.01%
+10,000
New +$270K
ZM icon
463
Zoom
ZM
$25.8B
$222K 0.01%
+2,500
New +$206K
CHNG
464
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$219K 0.01%
+15,000
New +$222K
BHVN
465
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$219K 0.01%
+5,000
New +$282K
PLMR icon
466
Palomar
PLMR
$3.65B
$216K 0.01%
+9,004
New +$198K
GEL icon
467
Genesis Energy
GEL
$1.84B
$213K 0.01%
9,730
-15,270
-61% -$340K
XLRN
468
DELISTED
Acceleron Pharma
XLRN
$205K 0.01%
5,000
UROV
469
DELISTED
Urovant Sciences Ltd.
UROV
$198K 0.01%
25,000
+10,000
+67% +$82K
HRTX icon
470
Heron Therapeutics
HRTX
$86.3M
$186K ﹤0.01%
+10,000
New +$200K
DVAX
471
DELISTED
Dynavax Technologies
DVAX
$180K ﹤0.01%
45,000
PRTK
472
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$176K ﹤0.01%
44,000
ADAP
473
DELISTED
Adaptimmune Therapeutics
ADAP
$161K ﹤0.01%
40,000
-25,000
-38% -$102K
KPTI icon
474
Karyopharm Therapeutics
KPTI
$168M
$150K ﹤0.01%
1,667
CLVS
475
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$149K ﹤0.01%
10,000
-15,000
-60% -$271K

Similar funds

Weiss Multi-Strategy Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, Weiss Multi-Strategy Advisers held 695 positions worth $3.78B, down 5.8% from $4.01B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $264M in Q2 2019, closing 212 positions and reducing 142 holdings. Its most notable exit was Regency Centers, an estimated $60.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in SPIRIT REALTY CAPITAL, INC. worth $51.2M.

  • Weiss Multi-Strategy Advisers's largest Q2 2019 buy was SPIRIT REALTY CAPITAL, INC.: 1,200,284 shares worth $51.2M.
  • Weiss Multi-Strategy Advisers added most to VICI Properties in Q2 2019, an estimated $50.3M increase.
  • Weiss Multi-Strategy Advisers's biggest Q2 2019 reduction was Douglas Emmett, cutting an estimated $53M.
  • Weiss Multi-Strategy Advisers fully exited Regency Centers in Q2 2019, selling an estimated $60.1M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 23% of its $3.78B portfolio in Q2 2019.
  • Weiss Multi-Strategy Advisers opened 198 new positions and closed 212 in Q2 2019.
  • Weiss Multi-Strategy Advisers's portfolio value fell 5.8% quarter-over-quarter to $3.78B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.